Connection
Edward Yeh to DNA Topoisomerases, Type II
This is a "connection" page, showing publications Edward Yeh has written about DNA Topoisomerases, Type II.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.736 |
|
|
|
-
Vejpongsa P, Yeh ET. Topoisomerase 2?: a promising molecular target for primary prevention of anthracycline-induced cardiotoxicity. Clin Pharmacol Ther. 2014 Jan; 95(1):45-52.
Score: 0.456
-
Yeh ETH, Ewer MS, Moslehi J, Dlugosz-Danecka M, Banchs J, Chang HM, Minotti G. Mechanisms and clinical course of cardiovascular toxicity of cancer treatment I. Oncology. Semin Oncol. 2019 12; 46(6):397-402.
Score: 0.174
-
Zhang S, Liu X, Bawa-Khalfe T, Lu LS, Lyu YL, Liu LF, Yeh ET. Identification of the molecular basis of doxorubicin-induced cardiotoxicity. Nat Med. 2012 Nov; 18(11):1639-42.
Score: 0.107